- View programme as: Grid view List view
- Print: Print
- Search
- Personal Planner
Sat 16 March
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, Room 22
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, Room 22
-
ESU Course 12 - Guideline updates and controversies: Incontinence, bladder / paediatric stones and male LUTS
Guideline updates and controversies: Incontinence, bladder / paediatric stones and male LUTS ESU Course 12
Guideline updates and controversies: Incontinence, bladder / paediatric stones and male LUTS
ESU Course 12
-
Location:Green Area, Room 22
-
Chair:
-
Aims and objectives of this session This course will focus on 3 non-oncology guidelines (Urinary Incontinence, Non-Neurogenic Male LUTS and Urolithiasis).
There will be a brief review of the EAU guidelines methodology and process of guideline development.
The course will then involve an interactive discussion of the main new changes to these guidelines, challenges in development, areas of inconsistency and opportunities for further research.
-
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Red Area, eURO Auditorium 1
-
Red Area, eURO Auditorium 2
-
Green Area, Room 1
-
Green Area, Room 2
-
Green Area, Room 3
-
Green Area, Room 4
-
Green Area, Room 5
-
Green Area, Room 10
-
Green Area, Room 11
-
Green Area, Room 12
-
Green Area, Room 19
-
Green Area, Room 20
-
Green Area, Room 17
-
Green Area, Room 18
-
Green Area, Room A
-
Green Area, Room B
-
Green Area, Room 13
-
Green Area, Room 14
-
Green Area, Room 15
-
Green Area, Room 16
-
Green Area, Room 21
-
Green Area, Room 22
-
Green Area, Room 23
-
Green Area, Room 6
-
Green Area, Room 7
-
Green Area, Room 8
-
Green Area, Room 9
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Red Area, eURO Auditorium 1
-
Plenary Session 3 - Imaging in prostate cancer: Is it time to change paradigms?
Imaging in prostate cancer: Is it time to change paradigms? Plenary Session 3
Imaging in prostate cancer: Is it time to change paradigms?
Plenary Session 3
-
Location:Red Area, eURO Auditorium 1
-
Chairs:
-
Aims and objectives of this session The aim of this session is to discuss recent changes in the diagnostic pathway of clinically localized prostate cancer. In particular, the role of novel imaging techniques and biopsy approaches such as multiparametric MRI and MRI-targeted biopsy for the diagnosis of prostate cancer will be assessed. In addition, the impact of imaging-directed therapies both in the primary and salvage setting will be critically evaluated and discussed. Finally, the European Association of Nuclear Medicine (EANM) lecture will be focused on the role of theranostics in the future of functional imaging.
Conclusion / voting
Debate Critical assessment of image-guided therapy of prostate cancer Discussion / voting
Debate PET imaging in prostate cancer: Improvement or waste of money? Discussion
Discussion
-
-
Plenary Session 5 - Prostate cancer
Prostate cancer Plenary Session 5
Prostate cancer
Plenary Session 5
-
Location:Red Area, eURO Auditorium 1
-
Chairs:
-
Aims and objectives of this session This session aims to debate on some controversial topics in the field of prostate cancer in a novel, interactive way. Each speaker will expose his or her view on the subject and then will be challenged by a multi-disciplinary jury composed by key figures involved in the clinical decision-making process of prostate cancer. Finally, the role of mp-MRI as a possible triage test before first biopsy will be discussed in terms of utility and cost-effectiveness. The session also includes the AUA lecture on prostate cancer.
Controversies in the management of prostate cancer: The jury is out Recent advances in prostate cancer: Real game changers? -
-
Plenary Session 7 - What is the optimal treatment for patients with male LUTS?
What is the optimal treatment for patients with male LUTS? Plenary Session 7
What is the optimal treatment for patients with male LUTS?
Plenary Session 7
-
Location:Red Area, eURO Auditorium 1
-
Chairs:
-
Aims and objectives of this session There is a wide variety of options for treatment of male LUTS. In this session game changing studies will be presented and discussed. In addition various new interventional techniques will be compared to established ones with the help of ease based discussions.
The second part of this sessions is reserved for a summing up of the entire meeting: top experts will give an overview of the best contributions of the 2019 meeting and their impact in the upcoming years.
Game changer Study: Upstream Case 1 Standard patient eligible for surgery: 60 kg, 60 grams and 60 years old Case 2 Same patient with strong wish to preserve ejaculation Case 3 Big prostate 150 gram Case 4 75 years old, 4 stents on clopidogrel, cannot stop. Prostate 70 gram, retention Souvenir sessions -
-
Plenary Session 1 - Bladder cancer in the young patient: Unique aspects
Bladder cancer in the young patient: Unique aspects Plenary Session 1
Bladder cancer in the young patient: Unique aspects
Plenary Session 1
-
Location:Red Area, eURO Auditorium 1
-
Chairs:
-
Aims and objectives of this session In young patients with bladder cancer the physician is faced with unique aspects associated with younger age. This session focusses on special challenges such as preserving fertility and the problems of pregnancy and delivery after urinary diversion and also addresses the role of developing diagnostic and therapeutic options in the younger patient. Specific molecular aspects and pathways and perspectives in the use of systemic immunotherapy in that setting will also be discussed extensively.
Fertility in the young female patient with bladder cancer Immunotherapy in localised disease Case-based debate No evidence of disease after neoadjuvant chemotherapy for MIBC: What next? -
-
Thematic Session 11 - Latest and hot news in medical treatment in onco-urology
Latest and hot news in medical treatment in onco-urology Thematic Session 11
Latest and hot news in medical treatment in onco-urology
Thematic Session 11
-
Location:Red Area, eURO Auditorium 1
-
Chairs:
-
Aims and objectives of this session Several new, potentially practice-changing data are released annually in the field of genito-urinary cancers. These studies involve not only Urologists but also Medical Oncologists and Radiation Therapists, highlighting the true multi-disciplinary approach beyond the treatment of these tumours. This session aims to update the audience about the results of the new trials presented at the major international meetings in 2018 and early 2019 using a novel, multi-disciplinary format.
Conclusions from recent oncology meetings regarding: -
-
Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS) - Technology development never ends!
Technology development never ends! Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
Technology development never ends!
Meeting of the EAU Section of Uro-Technology (ESUT), in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
-
Location:Red Area, eURO Auditorium 1
-
Chair:
-
Aims and objectives of this session Following a more than 10-year tradition of live-surgery sessions, the EAU Section of Uro-Technology (ESUT) presents an ambitious programme focusing on novel techniques and technologies in endourological, laparoscopic and robotic-assisted procedures. This year, we want to focus on novel technology improving the performance of video-assisted surgery and diagnostics in all fields of Endourology. This session is conducted in collaboration with the the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS).
In the laparoscopic and robot-assisted cases, we will focus on the developments of imaging as well as on new instruments and devices that improve its ergonomics. The latest digital developments for flexible endoscopy of the upper urinary tract for diagnosis and treatment of tumours and calculi will also be demonstrated. ESUT faculty consists of internationally well-known experts serving as surgeons and moderators. The different surgical procedures will be transmitted from Fundacio Puigvert Hospital, Barcelona in high definition and 3D quality. Traditionally, the format of ESUT Live Surgery will allow all delegates to directly communicate with the surgeons to ask questions and to discuss every aspect of the procedure. In addition, the ESUT session will also be available online.
Live broadcasts from Fundacio Puigvert Hospital, Barcelona (ES) Live surgery - Part I Live surgery - Part II Pre-recorded video Bipolar enucleation of prostate To be confirmed
Live surgery - Part III Live surgery - Part IV -
-
Video Session 07 - Updates on partial nephrectomy techniques
Updates on partial nephrectomy techniques Video Session 07
Updates on partial nephrectomy techniques
Video Session 07
V46Laparoscopic resection of intraparenchymal kidney neoplasm in condition of warm ischemia
By: Popov S. , Guseinov R. , Orlov I. , Katunin A.
Institutes: City Hospital Saint Luka, Dept. of Urology, Saint Petersburg, Russia
V47Bilateral kidney tumor: Management and feasibility
By: Sforza S. , Campi R. , Mari A. , Di Maida F. , Tellini R. , Vanacore D. , Grosso A. , Barzaghi P. , Siena G. , Masieri L. , Carini M. , Minervini A.
Institutes: University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy
V48Robot-assisted partial nephrectomy: Techniques and outcomes from the Transatlantic Robotic Nephron-sparing Surgery (TRoNeS) study group
By: Casale P. 1 , Lughezzani G. 1 , Buffi N. 1 , Maffei D. 1 , Dell'Oglio P. 2 , Paciotti M. 1 , Fasulo V. 1 , Domanico L. 1 , Bevilacqua G. 1 , Saita A. 1 , Lazzeri M. 1 , Hurle R. 1 , Guazzoni G.F. 1 , Porter J. 3 , Mottrie A. 2
Institutes: 1Humanitas Clinical and Research Center, Dept. of Urology, Rozzano, MI, Italy, 2Onze-Lieve-Vrouw Hospital, Dept. of Urology, Aalst, Belgium, 3Swedish Medical Center, Dept. of Urology, Seattle, WA, United States of America
V49Non-ischemic partial nephrectomy with the hydrojet resection technique
By: Gakis G. , Schubert T. , Hassan F. , Sokolakis I. , Ölschläger M. , Hatzichristodoulou G. , Kübler H.
Institutes: University Hospital of Würzburg, Julius Maximillians University, Dept. of Urology and Pediatric Urology, Würzburg, Germany
V50Image-guided robot-assisted partial nephrectomy (IGRAPN): Combining 3 imaging techniques to perform an anatomical zero ischemia hemi-nephrectomy
By: Gury L. , Grande P. , Bernhard J-C.
Institutes: CHU Pellegrin, Dept. of Urology, Bordeaux, France
V51Robot-assisted partial nephrectomy for complex (PADUA score ≥10) tumors: Results from a multicenter experience at four high-volume centers
By: Buffi N. 1 , Lughezzani G. 1 , Maffei D. 1 , Dell'Oglio P. 2 , Casale P. 1 , Saita A. 1 , Guazzoni G.F. 1 , Porter J. 3 , Porpiglia F. 4 , Fiori C. 4 , Amparore D. 5 , Mottrie A. 2
Institutes: 1Humanitas Clinical and Research Center, Dept. of Urology, Milan, Italy, 2Onze-Lieve-Vrouw Hospital, Dept. of Urology, Aalst, Belgium, 3Swedish Urology Group, Dept. of Urology, Seattle, United States of America, 4San Luigi Gonzaga Hospital, Division of Urology, Dept. of Oncology, Turin, Italy, 5San Luigi Gonzaga Hospital, Division of Urology, Department of Oncology, Turin, Italy
V52Robot-assisted partial nephrectomy in a patient with multiple tumor lesions in an S-shaped kidney: Superselective arterial clamping guided by the use of 3D images generated by a dedicated software
By: Annino F. 1 , Fuschi A. 2 , Pastore A.L. 2 , Carbone A. 3 , Al Salhi Y. 2 , De Angelis M. 1 , Asimakopoulos A. 1
Institutes: 1San Donato Hospital, Dept. of Urology, Arezzo, Italy, 2Sapienza University of Rome, Medico-Surgical Sciences and Biotechnologies, Latina, Italy, 3Sapienza University of Rome , Medico-Surgical Sciences and Biotechnologies, Latina, Italy
-
Video Session 10 - Advancements in benign prostatic hyperplasia treatment and prostate biopsy
Advancements in benign prostatic hyperplasia treatment and prostate biopsy Video Session 10
Advancements in benign prostatic hyperplasia treatment and prostate biopsy
Video Session 10
V67First 3D holmium laser enucleation of the prostate (3D-HoLEP)
By: Sanchez Macias J. 1 , Franco M. 1 , Pardo A. 2 , Camacho Rovira D. 1 , Calaf O. 3 , Mercader C. 1 , Alcaraz A. 1
Institutes: 1Hospital Clinic, Dept. of Urology, Barcelona, Spain, 2Laseralia, C.E.O., Barcelona, Spain, 3hospital Germans Trias, Dept. of Urology, Badalona, Spain
V68Urethra and ejaculation preserving robot-assisted simple prostatectomy: Near infrared fluorescence imaging-guided Madigan technique
By: Simone G. , Misuraca L. , Anceschi U. , Minisola F. , Ferriero M. , Guaglianone S. , Tuderti G. , Gallucci M.
Institutes: Regina Elena National Cancer Institute, Dept.of Urology, Rome, Italy
V69Transurethral bipolar-plasmakinetic endoscopic enucleation of prostate exceeding 200g: Tips ans tricks with 24 cases results
By: Zou Z. , Liang C.
Institutes: The First Affiliated Hospital of Anhui Medical University, Dept. of Urology, Heifei, China
V70Holmium laser enucleation of the prostate: Tips and tricks to reduce incontinence
By: Maheshwari P. 1 , Chaurasia A 1 , Okwi N. 2 , Mukasa N.V. 3
Institutes: 1Fortis Hospital Mulund, Dept. of Urology, Mumbai, India, 2Busitema University, Dept. of Surgery, Faculty of Health Sciences , Busetima, Uganda, 3Mulago National Hospital, Dept. of Surgery, Kampala, Uganda
V71Endoscopic enucleation of the prostate: A step by step approach
By: Enikeev D. , Rapoport L. , Taratkin M. , Glybochko P.
Institutes: Sechenov University, Institute for Urology and Reproductive Health, Moscow, Russia
V72Freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anesthesia: A video demonstration
By: Shahin O. 1 , Kwiatkowski M. 2 , Wyler S. 2
Institutes: 1Uromerian.ch, Praxis an der Merian Iselin Klinik, Basel, Switzerland, 2Kantonsspital Aarau, Dept. of Urology, Aarau, Switzerland
V73Local anaesthetic transperineal prostate (LATP) biopsy using the precision point access system: A step-by-step video
By: Campbell A. 1 , Omer A.E. 1 , Popert R. 2 , Lamb A. 1
Institutes: 1University of Oxford, Nuffield Dept. of Surgical Sciences, Oxford, United Kingdom, 2Guys Hospital, Dept. of Urology, London, United Kingdom
-
Video Session 08 - Innovations and awards
Innovations and awards Video Session 08
Innovations and awards
Video Session 08
V533D digital reconstruction of renal model to improve preoperative planning of robot-assisted partial nephrectomy
By: Schiavina R. 1 , Bianchi L. 1 , Angiolini A. 1 , Barbaresi U. 1 , Bortolani B. 2 , Cercenelli L. 3 , Borghesi M. 1 , Chessa F. 1 , Gaudiano C. 4 , Sessagesimi E. 4 , Molinaroli E. 1 , D'Agostino S. 1 , Marcelli E. 3 , Brunocilla E. 1
Institutes: 1Sant'Orsola-Malpighi Hospital, University of Bologna, Dept. of Urology, Bologna, Italy, 2Sant'Orsola-Malpighi Hospital, University of Bologna, Dept. of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy, 3Sant'Orsola-Malpighi Hospital, University of Bologna, Dept. of Experimental, Diagnostic and Specialty Medicine , Bologna, Italy, 4Sant'Orsola-Malpighi Hospital, University of Bologna, Dept. of Radiology, Bologna, Italy
V54The crush carving technique using a soft coagulation device - a simple method for successful laparoscopic hemi-nephrectomy without hilar clamping
By: Komai Y. , Ishikawa Y. , Yasuoka S. , Inatsu H. , Fujiwara R. , Ogawa M. , Numao N. , Yuasa T. , Yamamoto S. , Yonese J.
Institutes: Cancer Institute Hospital of Japanese Foundation for Cancer Research, Dept. of Genitourinary Oncology, Tokyo, Japan
V55The use and applications of near infrared fluorescence using Indocyanine Green in robotic urology
By: Ahallal Y. 1 , Jeglinschi S. 1 , Chevallier D. 1 , Tibi B. 1 , Durand M. 1 , Messas A. 2
Institutes: 1CHU Nice, Dept. of Urology, Nice, France, 2Turin Urology Hospital, Dept. of Urology, Paris, France
V56The development of a 3D navigation system for robot-assisted partial nephrectomy using augmented reality technology
By: Sawada A. 1 , Hamada A. 1 , Sengiku A. 2 , Koeda M. 3 , Onishi K. 3 , Ogawa O. 1
Institutes: 1Kyoto University Graduate school of Medicine, Dept. of Urology, Kyoto, Japan, 2Sengiku Clinic, Dept. of Urology, Moriyama, Japan, 3Osaka Electro-Communication University, Dept. of Biomedical Engineering, Osaka, Japan
V57Exploring the parameters affecting stone retropulsion in holmium laser lithotripsy: A video analysis
By: Black K.M. 1 , Aldoukhi A.H. 1 , Roberts W.W. 1 , Hall T. 2 , Ghani K.R. 1
Institutes: 1University of Michigan, Dept. of Urology, Ann Arbor, United States of America, 2University of Michigan, Dept. of Engineering, Ann Arbor, United States of America
V58Renal cell carcinoma with inferior vena cava thrombus: 3D laparoscopic approach
By: Martos Calvo R. , Peri L. , D'Anna M. , Ribal M.J. , Alcaraz A.
Institutes: Hospital Clínic, Dept. of Urology, Barcelona, Spain
V593D elastic augmented reality robot-assisted partial nephrectomy for central and posterior renal masses: A new tool for a better resection of the tumor
By: Porpiglia F. , Checcucci E. , Amparore D. , Piramide F. , Piazzolla P. , Bellin A. , Fiori C.
Institutes: AOU San Luigi Gonzaga, Dept. of Urology, Turin, Italy
-
Video Session 11 - Management of complex urethral strictures
Management of complex urethral strictures Video Session 11
Management of complex urethral strictures
Video Session 11
V74Withdrawn
V75Oral grafts for urethral augmentation. Step-by-step harvesting technique from inner cheek and sublingual area
By: Campos Juanatey F. , Portillo Martin J.A , Correas Gomez M.A , Herrero Blanco E. , Calleja Hermosa P. , Varea Malo R. , Zubillaga Guerrero S. , Gutierrez Baños J.L
Institutes: Marques de Valdecilla University Hospital, Dept. of Urology, Santander, Spain
V76Bulbo-membranous urethroplasty with "BAES-flap": A description of the surgical technique
By: Gil-Vernet Sedo A. 1 , Céspedes M. 1 , Ropero J. 2 , Díaz F. 1
Institutes: 1Parc Sanitari Sant Joan de Déu, Dept. of Urology, Barcelona, Spain, 2Hospital Universitari Vall d’Hebron, Dept. of Urology, Barcelona, Spain
V77Anastomotic urethroplasty in first year of life
By: Kulkarni S. 1 , Joshi P.M.J 2
Institutes: 1Kulkarni Reconstructive Urology Center , Dept. of Reconstructive Urology , Pune, India, 2Kulkarni Reconstructive Urology Center , Dept. of Reconstructive Urology, Pune, India
V78Penile skin flap neourethra after radical penile amputation
By: Kulkarni S. , Bhadranwar S. , Rawal A. , Mousa A. , Joshi P.M.
Institutes: Kulkarni Reconstructive Urology Center, Reconstructive Urology, Pune, India
V79Augmented non-transected anastomotic urethroplasty (Kodama`s operation)
By: Kotov S.V.
Institutes: Pirogov Russian National Research Medical University, Dept. of Urology and Andrology, Moscow, Russia
V80Transperineal prerectal approach for the treatment of posterior urethral stricture after radical prostatectomy
By: Vitarelli A. 1 , Divenuto L. 2 , Vulpi M. 2 , Ditonno P. 2
Institutes: 1University of Bari "Aldo Moro", Urology and Andrology Unit, Department of Emergency and Organ Transplantation, Bari, Italy, 2University of Bari , Urology and Andrology Unit, Department of Emergency and Organ Transplantation, Bari, Italy
V81Ventral inlay and dorsal onlay buccal grating for long segment nearly obliterative to obliterative bulbar urethral strictures
By: Chawla A.K. , Kapadia A. , Odougar A. , Hegde P. , Binmohammed Z.
Institutes: Kasturba Medical College, Manipal University, Dept. of Urology and Renal Transplant, Manipal, India
-
Video Session 09 - New developments in robot-assisted prostatectomy
New developments in robot-assisted prostatectomy Video Session 09
New developments in robot-assisted prostatectomy
Video Session 09
V60Salvage robot-assisted laparoscopic prostatectomy: Does primary treatment make a difference?
By: Önol F.F. 1 , Bhat S. 1 , Rogers T. 1 , Jenson C. 1 , Roof S. 1 , Rocco B.M.C. 2 , Patel V. 1
Institutes: 1Florida Hospital Global Robotics Institute, Dept. of Urology, Celebration, United States of America, 2University of Modena and Reggio Emilia, Dept. of Urology, Modena, Italy
V61The Bollens' stitch: A modified technique for robot-assisted radical prostatectomy
By: Brassetti A. 1 , Bollens R. 2 , Turbanti A. 3 , Cardi A. 4 , De Vico A. 4 , Emiliozzi P. 4 , Iannello A. 4 , Proietti F. 5 , Riga T. 4 , Scapellato A. 4 , Tuffu G. 4 , D'Elia G. 4
Institutes: 1Regina Elena Hospital, Dept. of Urology, Rome, Italy, 2Université Nord de France, St. Phillibert Hospital, Dept. of Urology, Lille, France, 3Tor Vergata Hospital, Dept. of Urology, Rome, Italy, 4San Giovanni Hospital, Dept. of Urology, Rome, Italy, 5Umberto I Hospital, La Sapienza University, Dept. of Urology, Rome, Italy
V63Initial experience with da Vinci single port (SP) robot-assisted radical prostatectomies
By: Agarwal D.K. , Sharma V. , Viers B. , Frank I. , Tollefson M. , Gettman M.
Institutes: Mayo Clinic, Dept. of Urology, Rochester, United States of America
V64Standardized and simplified robot-assisted super-extended pelvic lymph node dissection for prostate cancer: The monoblock technique
By: Würnschimmel C. , Grande P. , Hyseni A. , Moschini M. , Baumeister P. , Mordasini L. , Mattei A.
Institutes: Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland
V65Pure single-site trans-perineal robotic radical prostatectomy: First clinical report using the SP® surgical system
By: Bertolo R.G. , Garisto J. , Eltemamy M. , Kaouk J.
Institutes: Cleveland Clinic, Dept. of Urology, Cleveland, United States of America
V66Innovations and techniques allowing surgical tailoring in patients with prostatic adenocarcinoma
By: Rocco B.M.C. 1 , Puliatti S. 1 , Eissa A. 2 , Elsherbiny A. 2 , Inzillo R. 1 , Micali S. 1 , De Carne C. 1 , Patel V. 3 , Bianchi G. 1 , Sighinolfi M.C. 1
Institutes: 1University of Modena and Reggio Emilia, Dept. of Urology, Modena, Italy, 2Tanta University, Dept. of Urology, Faculty of Medicine, Tanta, Italy, 3Global Robotic Institute, Dept. of Urology, Orlando, United States of America
-
Video Session 12 - Alternative approaches to complex genital surgery
Alternative approaches to complex genital surgery Video Session 12
Alternative approaches to complex genital surgery
Video Session 12
V82How to improve your Xiapex results in Peyronie’s disease: The percutaneous needle tunnelling (PNT) technique. Step-by-step surgical video
By: Fernandez Pascual E. 1 , González-García F.J. 2 , García-Criado E. 1 , Souto A.D. 1 , Marcos D. 1 , Angulo J. 3 , Carballido J. 1 , Martínez-Salamanca J.I. 1
Institutes: 1University Hospital Puerta de Hierro-Majadahonda, Dept. of Urology, Madrid, Spain, 2Lyx Institute of Urology, Dept. of Urology, Madrid, Spain, 3Institute Ramón y Cajal of Health Research (IRYCIS), Dept. of Histology, Madrid, Spain
V83Surgical treatment of Peyronie’s disease with buccal mucosa graft
By: Kotov S.V. , Usufov A.G.
Institutes: Pirogov Russian National Research Medical University, Dept. of Urology and Andrology, Moscow, Russia
V84Robotic sigmoid vaginoplasty: A feasible single stage minimally invasive alternative
By: Khandekar A. , Pandey S. , Abraham B. , Mohammad A.I.
Institutes: Kokilaben Dhirubhai Ambani Hospital, Dept. of Urology, Mumbai, India
V85From pubis to phallus: A complete demonstration of the three stages of radial artery forearm phalloplasty formation
By: Chiriacò G. , Blecher G.A. , Christopher A.N. , Ralph D.J.
Institutes: University College London Hospital (UCLH), Dept. of Andrology, London, United Kingdom
V86Gender affirming surgery: Vaginoplasty and clitoroplasty with modified peno-scrotal flap technique
By: Trombetta C. , Migliozzi F. , Rizzo M. , Bucci S. , Perin C. , Boltri M. , Claps F. , Liguori G.
Institutes: ASUITS, Faculty of Medicine and Surgery, Dept. of Urology, Trieste, Italy
V87Revision of inflatable penile prosthesis in a patient with prosthetic malfunction and glans ischemia
By: Kocjancic E. , Acar O. , Morgantini L.A. , Halgrimson W.
Institutes: University of Illinois at Chicago, Dept. of Urology, Chicago, United States of America
V88Video-endoscopic inguinal lymphadenectomy: 48 cases
By: Molina Bravo M. , Farrés Rabanal A. , López Martínez P. , Gutiérrez Carrillo G. , Fernández Samos D. , García Sanz M. , De Arriba Alonso M. , Alonso Prieto M.A.
Institutes: Hospital of Leon, Dept. of Urology, Leon, Spain
V89Laparoscopic (robot-assisted) VEIL - a single centre experience
By: Srivathsan R. , Yuvaraja T.
Institutes: Kokilaben Dhirubhai Ambani Hospital, Dept. of Robotic Urooncology, Mumbai, India
-
Opening Ceremony - EAU Opening Ceremony
EAU Opening Ceremony Opening Ceremony
EAU Opening Ceremony
Opening Ceremony
-
Location:Red Area, eURO Auditorium 1
Opening address To be confirmed
Announcement of the new EAU Honorary Members
Presentation of the EAU Willy Gregoir Medal 2019
Presentation of the EAU Frans Debruyne Life Time Achievement Award 2019
Presentation of the EAU Crystal Matula Award 2019
Presentation of the EAU Hans Marberger Award 2019
EAU Innovators in Urology Award
EAU Ernest Desnos Prize 2019
Presentation of the EAU Prostate Cancer Research Award 2019
-
-
Networking Reception
Networking Reception
-
-
Red Area, eURO Auditorium 2
-
Plenary Session 4 - Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma (RCC) Plenary Session 4
Renal Cell Carcinoma (RCC)
Plenary Session 4
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session The majority of renal tumours are nowadays diagnosed as small renal mass. During this session the pros and cons of various surgical approaches and alternative treatments will be discussed by distinguished experts. In locally advanced and metastatic RCC the timing and role of tumour nephrectomy is under debate. This session will summarise recent data and ongoing clinical trials and discuss their impact on current treatment algorithms.
Minimally-invasive partial nephrectomy Case-based debate Small renal mass in the young and obese: Knife, needle or nothing? Discussion
Debate Cytoreductive nephrectomy: Does CARMENA change everything? Rebuttal
Rebuttal
Discussion
-
-
Plenary Session 6 - The role of the urologist in sexual and fertility issues of cancer survivorship
The role of the urologist in sexual and fertility issues of cancer survivorship Plenary Session 6
The role of the urologist in sexual and fertility issues of cancer survivorship
Plenary Session 6
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session As more men achieve long-term survival after urogenital cancers, sexual dysfunction and infertility have increasingly been recognized as negative consequences that impact quality of life in cancer survivors. The surgeries we perform as urologists, including prostatectomy, retroperitoneal lymph node dissection and penile surgery can have profound and direct effects on sexual wellbeing and fertility. Furthermore, systemic therapies including chemotherapy and hormonal manipulation have been strongly associated to reductions in sexual function and sperm count. In this session, we will discuss these devastating side effects and provide guidance on how to deal with these issues in the daily practice.
Case-based debate Hypogonadal prostate cancer patient following treatment with curative intent Rebuttal and summary
-
-
Plenary Session 2 - Nightmare session: Stones
Nightmare session: Stones Plenary Session 2
Nightmare session: Stones
Plenary Session 2
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session Stones are everywhere. No urology unit can afford not to treat stones. Treatment has become a minimally-invasive daily business with low morbidity. However, pitfalls are everywhere and complications where nobody expects them are disappointing for urologists and patients. We will discuss some routine procedures leading to significant issues to identify risk factors and preventive strategies.
Case-based debate The forgotten stent Case-based debate Severe sepsis following ureteroscopy Case-based debate Bowel injury following percutaneous nephrolithotomy -
-
Poster Session 01 - The future is bright: Basic research in spinal cord injury
The future is bright: Basic research in spinal cord injury Poster Session 01
The future is bright: Basic research in spinal cord injury
Poster Session 01
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
1Effect of early sacral neuromodulation on bladder function in a rat model of incomplete spinal cord injury due to focal contusion
By: Jeong S.J. 1 , Yoon C.Y. 1 , Lee Y.J. 1 , Kim J.H. 2 , Song S.H. 1 , Ryu H.Y. 1
Institutes: 1Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 2Kangwon National University School of Medicine, Dept. of Urology, Chuncheon, South Korea
2Anti-Nogo-A antibodies: Promising treatment for neurogenic lower urinary tract dysfunction after spinal cord injury
By: Schneider M.P. 1 , Sartori M. 2 , Schwab E. 3 , Kessler M. 2
Institutes: 1Inselspital, Dept. of Urology, Bern, Switzerland, 2University of Zürich, Balgrist University Hospital, Dept. of Neuro-Urology, Spinal Cord Injury Center & Research, Zurich, Switzerland, 3University of Zürich, Brain Research Institute, Dept. of Health Sciences and Technology, Zurich, Switzerland
* 3Barrington’s nucleus CRH neurons conditionally drive bladder contraction: A multi-unit optogenetic recording study in mice
By: Ito H. , Sales A. , Tench B. , Drake M.J. , Pickering A.E.
Institutes: University of Bristol, School of Physiology, Pharmacology and Neuroscience, Bristol, United Kingdom
4Therapeutic effects of p38 MAP kinase inhibitor in storage and voiding dysfunction in mice with spinal cord injury (SCI)
By: Shimizu N. 1 , Suzuki T. 2 , Takaoka E. 3 , Shimizu T. 3 , Hirayama A. 4 , Uemura H. 1 , Kanai A A.J. 5 , De Groat W.C. 6 , Yoshimura N. 3
Institutes: 1Kindai University, Dept. of Urology, Faculty of Medicine, Osaka-Sayama, Japan, 2Hamamatsu University school of Medicine, Dept. of Urology, Hamamatsu, Japan, 3University of Pittsburgh, Dept. of Urology, Pittsburgh, United States of America, 4Kindai University Nara Hospital, Dept. of Urology, Ikoma, Japan, 5University of Pittsburgh, Dept. of Medicine, Pittsburgh, United States of America, 6University of Pittsburgh, Dept. of Pharmacology and Chemical Biology, Pittsburgh, United States of America
5Improvement of bladder and urethral dysfunction by the early intervention with anti-BDNF antibody after spinal cord injury in mice
By: Wada N.W. 1 , Suzuki T. 2 , Tyagi P. 2 , Tsuchida M. 1 , Banjo H. 1 , Yoshimura N. 2 , Kakizaki H. 1
Institutes: 1Asahikawa Medical University, Dept. of Renal and Urologic Surgery, Asahikawa, Japan, 2University of Pittsburgh, Dept. of Urology, Pittsburgh, United States of America
* 6High field single subject brain mapping of pelvic floor motor control. A 7-Tesla fMRI study
By: Groenendijk I.M. 1 , Luijten S. 1 , Van Der Zwaag W. 2 , Holstege J.C 3 , Scheepe J. 1 , De Zeeuw C. 4 , Blok B. 1
Institutes: 1Erasmus Medical Center, Dept. of Urology, Rotterdam, The Netherlands, 2Spinoza Center for Neuroimaging, Dept. of Neuroimaging, Amsterdam, The Netherlands, 3Erasmus Medical Center, Dept. of Neuroscience, Rotterdam, The Netherlands, 4Netherlands Institute for Neuroscience, Dept. of Neuroscience, Amsterdam, The Netherlands
7Muscarinic receptor expression in spinal cord transected rats with early anticholinergic treatment
By: Loutochin G. 1 , Przydacz M. 1 , Cammisotto P. 2 , Biardeau X. 1 , Campeau L. 2 , Corcos J. 1
Institutes: 1Jewish General Hospital, Dept. of Urology, Montreal, Canada, 2Lady Davis Institute, Dept. of Urology, Montreal, Canada
8Urinary TIMP-2 is significantly associated with poor bladder compliance and upper urinary tract damage in adult patients with spina bifida
By: Peyronnet B. 1 , Richard C. 1 , Bendavid C. 2 , Naudet F. 3 , Hascoet J. 1 , Brochard C. 4 , Alimi Q. 1 , Khene Z. 1 , Siproudhis L. 5 , Bouguen G. 6 , Kerdraon J. 7 , Manunta A. 1 , Gamé X. 8
Institutes: 1Rennes University Hospital, Dept. of Urology, Rennes, France, 2Rennes University Hospital , Dept. of Biochemistry, Rennes, France, 3University of Rennes, Inserm CIC, Rennes, France, 4Rennes University Hospital , Dept. of Gastroenterology , Rennes, France, 5Rennes University Hospital, Dept. of Gastroenterology, Rennes, France, 6Rennes university Hospital, Dept. of Gastroenterology, Rennes, France, 7Centre de Rééducation de Kerpape, Dept. of Rehabilitation, Ploemeur, France, 8Toulouse University Hospital, Dept. of Urology, Toulouse, France
9Nerve growth factor-mediated Na+ channel plasticity of bladder afferent neurons in mice with spinal cord injury
By: Gu B. 1 , Ni J.S. 1 , Yoshimura N. 2
Institutes: 1Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Dept. of Urology, Shanghai, China, 2University of Pittsburgh, School of Medicine, Dept. of Urology, Pittsburgh, United States of America
10Physiopathology of neurogenic detrusor overactivity: Role of neurotrophins, inflammation and extracellular matrix according to the neurological disease
By: Richard C. 1 , Bendavid C. 1 , Hascoet J. 1 , Alimi Q. 1 , Khene Z-E. 1 , Kerdraon J. 1 , Manunta A. 1 , Gamé X. 2 , Peyronnet B. 1
Institutes: 1University of Rennes, Dept. of Urology, Rennes, France, 2University of Toulouse, Dept. of Urology, Toulouse, France
11Bladder primary afferent pathways to the spinal cord in mice
By: Takezawa K. 1 , Ueda N. 1 , Sekii Y. 1 , Inagaki Y. 1 , Fukuhara S. 1 , Kiuchi H. 1 , Kondo M. 2 , Shimada S. 2 , Nonomura N. 1
Institutes: 1Osaka University Medical School, Dept. of Urology, Suita, Japan, 2Osaka University Medical School, Dept. of Neuroscience and Cell Biology, Suita, Japan
12Injecting RNA interference lentiviruses targeting the muscarinic 3 receptor gene into the bladder wall inhibits neurogenic detrusor overactivity in rats with spinal cord injury
By: Shang Z. , Ou T.
Institutes: Xuanwu Hospital Capital Medical University, Dept. of Urology, Beijing, China
-
-
Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG - New modalities in diagnosis and treatment in oncology
New modalities in diagnosis and treatment in oncology Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG
New modalities in diagnosis and treatment in oncology
Joint meeting of the EAU Section of Oncological Urology (ESOU), the EAU Robotic Urology Section (ERUS), the EAU Section of Uro-Technology (ESUT) and with the ECCO, EORTC GUCG, ESMO, ESSO, ESTRO and EUOG
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session To give an update on diagnosis and treatment of urological malignancies. The importance of new technologies and training facilities for young European urologists will be illustrated together. Basic science advancements in onco-urology will be also presented and discussed with the audience.
The European Uro-Oncology Group (EUOG) Discussion
The European Cancer Organisation (ECCO) Discussion
The European SocieTy for Radiotherapy & Oncology (ESTRO) Discussion
The European Society for Medical Oncology (ESMO) Discussion
The European Organisation for Research and Treatment of Cancer Genito-Urinary Cancer Group (EORTC GUCG) Discussion
The European Society of Surgical Oncology (ESSO) Discussion
ESOU-ESUR-ESUT: Advances in diagnosis and treatment of cancer
Discussion
Discussion
Debate Focal therapy in intermediate risk patients Discussion
Discussion
Discussion
Discussion
Debate Robotic radical nephrectomy for locally-advanced renal cancer Discussion
Debate Renal-sparing surgery for T2 Renal Cell Carcinoma (RCC): Always indicated? Discussion
Debate Conservative treatment of MI Upper urinary tract tumours: Any role? Discussion
-
-
Thematic Session 19 - Semi-live surgery: Cystectomy and urinary diversion
Semi-live surgery: Cystectomy and urinary diversion Thematic Session 19
Semi-live surgery: Cystectomy and urinary diversion
Thematic Session 19
-
Location:Red Area, eURO Auditorium 2
-
Discussants:
-
Aims and objectives of this session Cystectomy and urinary diversion is one of the most difficult procedures in uro-oncological surgery. This session will present tipps and tricks in robotic and open procedures including to deal with complications of the approaches. Videos will be presented and discussed by the surgeon and a distinguished panel.
Questioned by discussants
Questioned by discussants
Questioned by discussants
-
-
Specialty Session - European Urology - Novel treatment strategies in Benign Prostatic Obstruction (BPO): A video-based course on the procedural essentials
Novel treatment strategies in Benign Prostatic Obstruction (BPO): A video-based course on the procedural essentials Specialty Session - European Urology
Novel treatment strategies in Benign Prostatic Obstruction (BPO): A video-based course on the procedural essentials
Specialty Session - European Urology
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session The Surgery-in-Motion session is dedicated to novel treatment strategies in BPO. Experts in the field will provide explanations and video demonstrations of various surgical techniques and discuss why they do it “their way”. Questions from the audience are welcome.
New immediate ablative techniques: Aqua-ablation -
-
Poster Session 06 - Understanding of LUTS mechanisms: New insights
Understanding of LUTS mechanisms: New insights Poster Session 06
Understanding of LUTS mechanisms: New insights
Poster Session 06
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
* 72Parameters for detrusor underactivity in women: Predictive value towards ineffective voiding in a large cohort of women with urinary incontinence
By: Rosier P.
Institutes: University Medical Center Utrecht, Dept. of Urology, Utrecht, The Netherlands
73Development of mathematical formulas for the prediction of outflow obstruction on an individual basis: A post-hoc analysis of the flow resistive forces index (QRF) study
By: Spyropoulos E. 1 , Spyropoulos K. 2
Institutes: 1Private practice, Dept. of Urology, Paleo Faliro, Greece, 2University of Athens, School of Dentistry, Athens, Greece
75Sensitivity and specificity of neurotrophins as biomarkers of a neurogenic detrusor overactivity in multiple sclerosis patients
By: Philippova E.S. 1 , Bazhenov I. 2 , Zyryanov A. 2 , Bazarny V. 3 , Sazonov S. 4 , Volkova L. 5
Institutes: 1Ural State Medical University, Dept. of Urology , Ekaterinburg, Russia, 2Ural State Medical University, Dept. of Urology, Ekaterinburg, Russia, 3Ural State Medical University, Dept. of Laboratory Diagnosis, Ekaterinburg, Russia, 4Ural State Medical University, Dept. of Histology, Cytology and Embriology, Ekaterinburg, Russia, 5Ural State Medical University, Dept. of Neurology , Ekaterinburg, Russia
76Detecting differences with magnetoencephalography (MEG)-urodynamics study of somatosensory processing normal desire to void and maximum desire to void sensation
By: Kitta T. 1 , Shiraishi H. 2 , Yagyu K. 2 , Shimojo A. 2 , Egawa K. 2 , Kanno Y. 1 , Ouchi M. 1 , Higuchi M. 1 , Togo M. 1 , Takahashi Y. 1 , Tsukiyama M. 1 , Moriya K. 1 , Ariga T. 2 , Shinohara N. 1
Institutes: 1Hokkaido University, Dept. of Urology, Sapporo, Japan, 2Hokkaido University, Dept. of Pediatrics, Sapporo, Japan
77Time to change microbiological approach to overactive bladder
By: Perovic S.U. 1 , Ksiezarek M. 1 , Rocha J. 1 , Vale L. 2 , Silva C. 2 , Dinis P. 2 , Antunes Lopes T. 2 , Peixe L. 1
Institutes: 1University of Porto, Faculty of Pharmacy, Porto, Portugal, 2Hospital de São João, University of Porto, Dept. of Urology, Faculty of Medicine, Porto, Portugal
* 78Dynamic connectivity in the periaqueductal gray matter measured by 7 Tesla functional MRI during a bladder filling protocol
By: De Rijk M.M. 1 , Van Den Hurk J. 2 , Rahnama'i M.S. 1 , Van Koeveringe G.A. 3
Institutes: 1Maastricht University, Dept. of Urology, Maastricht, The Netherlands, 2Scannexus, Maastricht, The Netherlands, 3Maastricht University, Medical Center, Dept. of Urology, Maastricht, The Netherlands
79Possible roles of urethral C-fiver afferents in storage/voiding dysfunction in female patients
By: Ichiyanagi O. 1 , Nishimoto K-I. 2 , Nagaoka A. 3 , Naito S. 4 , Yagi M. 4 , Ushijima M. 4 , Kajinuma A. 1 , Kato T. 4 , Tsuchiya N. 4
Institutes: 1Yamagata Prefectural Kahoku Hospital, Dept. of Urology, Kahoku, Japan, 2Seichokai Fuchu Hospital, Dept. of Urology, Izumi, Japan, 3Yonezawa City Hospital, Dept. of Urology, Yonezawa, Japan, 4Yamagata University Faculty of Medicine, Dept. of Urology, Yamagata, Japan
80Lower urinary tract symptoms amongst adult patients with genetically-confirmed mitochondrial disease
By: Sachdeva A. 1 , Feeney C. 1 , Gorman G. 1 , Turnbull D.M. 1 , Harding C. 2
Institutes: 1Newcastle University, Wellcome Centre for Mitochondrial Research, Newcastle upon Tyne, United Kingdom, 2Freeman Hospital, Dept. of Urology, Newcastle upon Tyne, United Kingdom
81Therapeutic effects of PDE9 inhibitor on lower urinary tract dysfunction (LUTD) in mice with spinal cord injury (SCI)
By: Shimizu N. 1 , Suzuki T. 2 , Takaoka E-I. 2 , Shimizu T. 2 , Hirayama A. 3 , Uemura H. 1 , Kanai A. 4 , De Groat W.C. 5 , Yoshimura N. 2
Institutes: 1Kindai University Faculty of Medicine, Dept. of Urology, Osaka-Sayama, Japan, 2University of Pittsburgh, Dept. of Urology, Pittsburgh, United States of America, 3Kindai University Nara Hospital, Faculty of Medicine, Dept. of Urology, Ikoma, Japan, 4University of Pittsburgh, Dept. of Medicine, Pittsburgh, United States of America, 5University of Pittsburgh, Dept. of Pharmacology and Chemical Biology, Pittsburgh, United States of America
83Three-dimensional model of MRI prostate in bladder outlet obstruction of male LUTS/BPH patients
By: Xia S. , Jie S.
Institutes: Renji Hospital, Dept. of Urology, Shanghai, China
84The role of prostatic apex shape in voiding symptom and urine flow: A development and validation study
By: Park J.S. , Lee K.S. , Koo K.C. , Chung B.H.
Institutes: Yonsei University College of Medicine, Dept. of Urology, Seoul, South Korea
-
-
Poster Session 60 - Minimising the risk of treatment in candidates for cystectomy
Minimising the risk of treatment in candidates for cystectomy Poster Session 60
Minimising the risk of treatment in candidates for cystectomy
Poster Session 60
835The role of cutaneous ureterostomy diversion: A multicenter analysis
By: Laura I. 1 , Lombardo R. 2 , Tema G. 2 , Cancrini F. 2 , Lotrecchiano G. 3 , Minervini A. 4 , Simone G. 5 , Cindolo L. 6 , D'Orta C. 6 , Ajami T. 1 , Antonelli A. 7 , Castellani D. 8 , Alcaraz A. 1 , De Nunzio C. 2
Institutes: 1Hospital Clinic of Barcelona, Urology, Dept. of Urology, Barcelona, Spain, 2Sapienza University of Rome, Sant'Andrea , Dept. of Urology, Rome, Italy, 3AORN “Rummo” Hospital, Dept. of Urology, Benevento, Italy, 4University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 5IFO, Istututo Nazionale Tumori Regina Elena Hospital, Dept. of Urology, Rome, Italy, 6San Pio da Pietralcina Hospital, Dept. of Urology, Vasto, Italy, 7Spedali Civili di Brescia Hospital, Dept. of Urology, Brescia, Italy, 8INRCA Hospital, Dept. of Urology, Ancona, Italy
836Utility of serum markers in the assessment of perioperative and postoperative morbidity and mortality after radical cystectomy for muscle invasive bladder cancer
By: Claps F. , Pavan N. , Rizzo M. , Boltri M. , Migliozzi F. , Liguori G. , Trombetta C.
Institutes: Urology Clinic, Dept. of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
837Impact of the number of radical cystectomies per hospital on 90-day mortality in Spain
By: Guijarro Cascales A. 1 , Llorente C. 1 , Hernandez V. 1 , Pérez-Fernández E. 2 , Fernández-Conejo G. 1 , De La Peña E. 1
Institutes: 1Hospital Universitario Fundación Alcorcón, Dept. of Urology, Madrid, Spain, 2Hospital Universitario Fundación Alcorcón, Research, Madrid, Spain
838Relative importance of the components of an eras protocol after radical cystectomy based on a multicenter prospective study (PRORAC)
By: Llorente C. 1 , Guijarro A. 1 , Passas J. 2 , Aguilar L. 2 , Hernandez C. 3 , Moralejo M. 3 , Gonzalez Enguita C. 4 , Husillos A. 4 , Ortiz F. 5 , Sanchez Chapado M. 5 , Carballido J. 6 , Castillón I. 6 , Mateo E. 7 , Romero I. 7 , Fernández Del Álamo J. 8 , Llanes L. 8 , Blázquez C. 9 , Sánchez Encinas M. 9 , Borrego J. 10 , Téllez M. 10 , Díez L. 11 , Carrero V.M. 11 , Hernandez V. 1 , Pérez-Fernánde E. 12 , García Del Valle S. 13
Institutes: 1Hospital Universitario Fundación Alcorcón, Dept. of Urology, Madrid, Spain, 2Hospital Universitario 12 de Octubre, Dept. of Urology, Madrid, Spain, 3Hospital Universitario Gregorio Marañón, Dept. of Urology, Madrid, Spain, 4Fundación Jimenez Díaz, Dept. of Urology, Madrid, Spain, 5Hospital Príncipe de Asturias, Dept. of Urology, Madrid, Spain, 6Hospital Universitario Puerta de Hierro- Majadahonda, Dept. of Urology, Madrid, Spain, 7Hospital de Getafe, Dept. of Urology, Madrid, Spain, 8Hospital Universitario de Torrejón, Dept. of Urology, Madrid, Spain, 9Hospital Universitario Rey Juan Carlos, Dept. of Urology, Madrid, Spain, 10Hospital Severo Ochoa, Dept. of Urology, Madrid, Spain, 11Hospital Infanta Leonor, Dept. of Urology, Madrid, Spain, 12Hospital Universitario Fundación Alcorcón, Dept. of Research, Madrid, Spain, 13Hospital Universitario Fundación Alcorcón, Dept. of Anesthesiology, Madrid, Spain
839Long term survival after radical cystectomy with respect to centralisation: Outcomes from 1110 patients treated at a single high-volume centre
By: Pang K.H. 1 , Novara G.H. 2 , Din O.S. 3 , Morgan S.L. 4 , Noon A.P. 5 , Catto J.W.F. 1 , Rosario D.J. 1
Institutes: 1University of Sheffield, Academic Urology Unit, Sheffield, United Kingdom, 2University of Padua, Dept. of Surgery, Oncology and Gastroenterology, Padua, Italy, 3Sheffield Teaching Hospitals NHS Foundation Trust, Cancer Research Centre, Sheffield, United Kingdom, 4Sheffield Teaching Hospitals NHS Foundation Trust, Dept. of Histopathology, Sheffield, United Kingdom, 5Sheffield Teaching Hospitals NHS Foundation Trust, Dept. of Urology, Sheffield, United Kingdom
840Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia
By: Fukushima H. , Kijima T. , Toide M. , Fukuda S. , Moriyama S. , Yasuda Y. , Uehara S. , Yoshida S. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Kihara K. , Fujii Y.
Institutes: Tokyo Medical and Dental University, Dept. of Urology, Tokyo, Japan
841Association of super extended lymphadenectomy at radical cystectomy with perioperative complications
By: D'Andrea D. , Soria F. , Gust K. , Seitz K. , Fajkovic H. , Remzi M. , Shariat S.
Institutes: Medical University of Vienna, Dept. of Urology, Vienna, Austria
842Association between antiplatelet or anticoagulant therapy and perioperative morbidity in patients undergoing radical cystectomy for urinary bladder cancer
By: Vetterlein M.W. , Gild P. , Bradtke M. , Klemm J. , Janisch F. , Soave A. , Dahlem R. , Fisch M. , Rink M.
Institutes: University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany
843Comparative effectiveness of robotic assisted and open radical cystectomy in contemporary cohorts of bladder cancer patients: An international multicenter collaboration
By: Zamboni S. 1 , Soria F. 2 , Mathieu R. 2 , Xylinas E. 3 , Tan W.S. 4 , Kelly J.D. 4 , Simone G. 5 , Gallucci M. 5 , Meraney A. 6 , Konety B. 7 , Antonelli A. 8 , Simeone C. 8 , Baumeister P. 1 , Mattei A. 1 , Montorsi F. 9 , Briganti A. 9 , Rink M. 10 , Aziz A. 11 , Karakiewicz P.I. 12 , Rouprêt M. 13 , Scherr D.S. 14 , Ploussard G. 15 , Sooriakumaran P. 16 , Shariat S.F. 2 , Moschini M. 17 , On behalf of the European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. On behalf of the EAU Research Foundation
Institutes: 1Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 2Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Dept. of Urology, Vienna, Austria, 3Bichat Hospital, Paris Descartes University, Dept. of Urology, Paris, France, 4Division of Surgery and Intervention Science, University College London, University College London Hospital, Dept. of Urology, London, United Kingdom, 5IRCCS, Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 6Hartford Healthcare Medical Group, Urology Division, Hartford, United States of America, 7University of Minnesota, Dept. of Urology, Minneapolis, United States of America, 8Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 9Urological Research Institute, San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy, 10University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 11University Medical Center Rostock, Dept. of Urology, Rostock, Germany, 12University of Montreal Health Centre, Cancer Prognostics and Health Outcomes Unit, Montreal, Canada, 13Pitié-Salpêtrière Academic Hospital, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris 6 University, Dept. of Urology, Paris, France, 14Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA, Dept. of Urology, New York, United States of America, 15La Croix du Sud, Dept. of Urology, Toulouse, France, 16University College London Hospital NHS Foundation Trust, Dept. of Uro-Oncology, London, United Kingdom, 17Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital , Dept. of Urology, Vienna, Austria
844Optimizing outcomes reporting after robot-assisted radical cystectomy: External validation of the USC-Pentafecta
By: Brassetti A. , Tuderti G. , Anceschi U. , Minisola F. , Guaglianone S. , Ferriero M. , Mastroianni R. , Flammia R.S. , Gallucci M. , Simone G.
Institutes: Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy
845Clinical recurrence after radical cystectomy for bladder cancer, defining optimal surveillance after surgery
By: Moschini M. 1 , Zamboni S. 1 , Karnes J.R. 2 , Montorsi F. 3 , Briganti A. 3 , Colombo R. 3 , Gallina A. 3 , Mattei A. 1 , Baumeister P. 1 , Di Trapani E. 4 , De Cobelli O. 4 , Musi G. 4 , Antonelli A. 5 , Simeone C. 5 , Boeri L. 2 , Soligo M. 2 , Simone G. 6 , Gallucci M. 6 , Aziz A. 7 , Xylinas E. 8 , Shariat S.F. 9 , On behalf of the European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group and of the EAU Research Foundation
Institutes: 1Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 2Mayo Clinic, Dept. of Urology, Rochester, United States of America, 3Urological Research Institute, San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy, 4European Institute of Oncology, Dept. of Urology, Milan, Italy, 5Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 6IRCCS Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 7University Medical Center Rostock, Dept. of Urology, Rostock, Germany, 8Bichat Hospital, Paris Descartes University, Dept. of Urology, Paris, France, 9Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Dept. of Urology, Vienna, Austria
847The impact of acute kidney injury on renal impairment and cardiovascular disease in patients with muscle invasive bladder cancer treated with radical cystectomy
By: Fujita N. 1 , Momota M. 1 , Tobisawa Y. 1 , Yoneyama T. 1 , Yamamoto H. 1 , Imai A. 1 , Hatakeyama S. 1 , Ito H. 2 , Yoneyama T. 1 , Hashimoto Y. 1 , Yoshikawa K. 3 , Ohyama C. 1
Institutes: 1Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan, 2Aomori Rosai Hospital, Dept. of Urology, Hachinohe, Japan, 3Mutsu General Hospital, Dept. of Urology, Mutsu, Japan
848ERAS concepts in the perioperative management of patients undergoing radical cystectomy for bladder cancer: Long-term-follow up and oncological outcome of a prospective randomized study
By: Ziegelmüller B.K. , Jokisch F. , Buchner A. , Grimm T. , Kretschmer A. , Schulz G. , Stief C.G. , Karl A.
Institutes: Großhadern Clinics, LMU, Dept. of Urology, Munich, Germany
849Feasibility of endoluminal partial cystectomy for urothelial cancer: First results from an animal hybrid model
By: Aufderklamm S. 1 , Kruck S. 2 , Hoffmans T. 1 , Aicher W.K. 1 , Hennenlotter J. 1 , Scharpf M. 3 , Stenzl A. 1 , Amend B. 1
Institutes: 1Eberhard Karls University, Dept. of Urology, Tübingen, Germany, 2Helios Klinikum Pforzheim, Dept. of Urology, Pforzheim, Germany, 3Eberhard Karls University, Dept. of Pathology, Tübingen, Germany
-
Poster Session 70 - Reducing complications and improving outcomes in cystectomy
Reducing complications and improving outcomes in cystectomy Poster Session 70
Reducing complications and improving outcomes in cystectomy
Poster Session 70
977Understanding risk factors associated with early unplanned reoperation after radical cystectomy and urinary diversion
By: Laymon M. , Ghobrial F.K. , Hashem A. , Abol-Enein H. , Shaaban A. , Mosbah A.
Institutes: Urology and Neprology Center, Dept. of Urology, Mansoura, Egypt
978Modified Wallace anastomosis reduces ureteroenteric stricture rates – prospective randomised study of ureteroenteric stricture rates after ileal conduit urinary diversion
By: Vukovic M. , Kavaric P. , Magdelinic A. , Pratljacic D. , Sabovic E. , Radovic N.
Institutes: Clinical centre of Montenegro, Dept. of Urology, Podgorica, Montenegro
979The impending need of a new disease specific comorbidity index for bladder cancer patients candidate to robot-assisted radical cystectomy
By: Lambert E. 1 , Dell’Oglio P. 2 , Vollemaere J. 1 , Uvin P. 1 , Goossens M. 1 , Van Der Jeugt J. 1 , Devos G. 1 , De Groote R. 1 , Turri F. 1 , Larcher A. 3 , Collins J. 4 , Schatteman P. 1 , De Naeyer G. 1 , D’Hondt F. 1 , Mottrie A. 2
Institutes: 1Onze Lieve Vrouw Hospital, Dept. of Urology, Aalst, Belgium, 2Onze Lieve Vrouw Hospital, Orsi Academy, Dept. of Urology, Aalst, Belgium, 3Urological Research Institute, IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 4Orsi Academy, Dept. of Urology, Aalst, Belgium
980Socioeconomic parameters as predictors of competing (non-bladder cancer) mortality after radical cystectomy
By: Fröhner M. 1 , Muallah D. 1 , Heberling U. 1 , Koch R. 1 , Hübler M. 2 , Borkowetz A. 1 , Wirth M.P. 1 , Thomas C. 1
Institutes: 1Technische Universität Dresden, Dept. of Urology, Dresden, Germany, 2Technische Universität Dresden, Dept. of Anesthesiology, Dresden, Germany
982Impact of neoadjuvant pembrolizumab on intra and peri-operative complications after radical cystectomy: A comparison with both standard chemotherapy and no adjuvant treatment
By: Zaffuto E. 1 , Moschini M. 2 , Burgio G. 1 , Scuderi S. 1 , Barletta F. 1 , Nocera L. 1 , Mirone V. 3 , Salonia A. 1 , Colombo R. 1 , Montorsi F. 1 , Briganti A. 1 , Necchi A. 4 , Gallina A. 1
Institutes: 1IRCCS Ospedale San Raffaele, Division of Oncology, Unit of Urology, Milan, Italy, 2Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 3University Federico II, Dept. of Urology, Naples, Italy, 4Fondazione IRCCS Istituto Nazionale Tumori, Division of Oncology, Unit of Urology, Milan, Italy
983Phase 1 clinical trial to evaluate the use of a tissue engineered neo-urinary conduit using adipose derived smooth muscle cells after radical cystectomy
By: Bivalacqua T. 1 , Steinberg G. 2 , Smith N. 2 , Joice G. 1 , Sopko N. 1 , Lerner S. 3 , Bochner B. 4 , Lee C. 5 , Rivera E. 6 , Jain D. 6 , Bertram T. 6 , Schoenberg M. 7
Institutes: 1Johns Hopkins University School of Medicine, Dept. of Urology, Baltimore, United States of America, 2University of Chicago, Dept. of Urology, Chicago, United States of America, 3Baylor College of Medicine, Dept. of Urology, Houston, United States of America, 4Memorial Sloan Kettering Cancer Center, Dept. of Urology, New York, United States of America, 5Ohio State University, Dept. of Urology, Columbis, United States of America, 6Tengion Regenerative Medicine, Dept. of Urology, Winston-Salem, United States of America, 7Albert Einstein School of Medicine, Dept. of Urology, Bronx, United States of America
984Comprehensive assessment of time-to-event data of perioperative short-term complications following radical cystectomy
By: Klemm J. , Rink M. , Gild P. , Janisch F. , Soave A. , Dahlem R. , Fisch M. , Vetterlein M.W.
Institutes: University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany
986Randomized controlled trial to compare the length of stay, perioperative outcomes and complications in patients undergoing radical cystectomy with and without the enhanced recovery after surgery (ERAS) protocol in a tertiary care centre in India
By: Nayak B. 1 , Bansal D 1 , Singh P. 1 , Seth A. 1 , Nayyar R. 1 , Ramachandran R. 2
Institutes: 1All India Institute of Medical Sciences, New Delhi, Dept. of Urology, New Delhi, India, 2All India Institute of Medical Sciences, New Delhi, Dept. of Anaesthesia, New Delhi, India
987Prospective randomized comparison of quality of life and sexual function between ileal neobladder versus sigmoid neobladder reconstruction following nerve sparing, vas sparing, seminal vesicle sparing and partial prostate sparing radical cystectomy
By: Singh V. , Sinha R.J. , Aggarwal A.J. , Pandey S.
Institutes: King George's Medical University, Dept. of Urology, Lucknow, India
988Patients with perioperative complications presented a higher risk of cancer specific mortality after radical cystectomy: A two year multicentre Italian real-life analysis
By: De Nunzio C. 1 , Cindolo L. 2 , Simone G. 3 , Lombardo R. 1 , Tema G. 1 , Leonardo C. 4 , Rocco B. 5 , Serni S. 6 , Schips L. 2 , Alvarez-Maestro M. 7 , Antonelli A. 8 , Bove P. 9 , Celia A. 10 , Cancrini F. 1 , Ceruti C. 11 , Crivellaro S. 12 , Falsaperla M. 13 , Frea B. 12 , Gallucci M. 3 , Lo Trecchiano G. 14 , Minervini A. 6 , Porreca A. 15 , Zaramella S. 16 , Tubaro A. 1
Institutes: 1Sapienza University of Rome, Sant'Andrea Hospital, Dept. of Urology, Rome, Italy, 2Padre Pio Da Pietralcina Hospital, Dept. of Urology, Vasto, Italy, 3Istituto Tumori Regina Elena, Dept. of Urology, Rome, Italy, 4Sapienza University of Rome, Umberto Primo Hospital, Dept. of Urology, Rome, Italy, 5Policlinico Di Milano, Dept. of Urology, Milan, Italy, 6Careggi Hospital, Dept. of Urology, Florence, Italy, 7University Hospital Infanta Sofia , Dept. of Urology, Madrid, Spain, 8University of Brescia, Dept. of Urology, Brescia, Italy, 9Tor Vergata University Hospital, Dept. of Urology, Rome, Italy, 10San Bassiano Hospital, Dept. of Urology, Bassano del Grappa, Italy, 11Le Molinette Hospital, Dept. of Urology, Turin, Italy, 12Santa Maria della Misericordia Hospital, Dept. of Urology, Udine, Italy, 13Vittorio Emanuele University Hospital, Dept. of Urology, Catania, Italy, 14G Rummo Hospital, Dept. of Urology, Benevento, Italy, 15Policlinico Di Albano, Dept. of Urology, Albano Terme, Italy, 16University Hospital Maggiore della Carità, Dept. of Urology, Novara, Italy
989Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care in Sweden – a nation-wide population based study
By: Liedberg F. 1 , Hagberg O. 2 , Aljabery F. 3 , Gårdmark T. 4 , Hosseini A. 5 , Jahnson S. 3 , Jancke G. 3 , Malmström P-U. 6 , Sherif A. 7 , Ströck V. 8 , Häggström C. 6 , Holmberg L. 6
Institutes: 1Institution of Translational Medicine, Lund University, Dept. of Urology, Malmö, Sweden, 2Institution of Translational Medicine, Lund University, Dept. of Urology, Lund, Sweden, 3Linköping University, Dept. of Clinical and Experimental Medicine, Linköping, Sweden, 4Karolinska Institute, Danderyd Hospital, Dept. of Clinical Sciences, Stockholm, Sweden, 5Karolinska University Hospital, Dept. of Urology, Stockholm, Sweden, 6Uppsala University, Dept. of Surgical Sciences, Uppsala, Sweden, 7Umeå University, Dept. of Surgical and Perioperative Sciences, Umeå, Sweden, 8Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Dept. of Urology, Gothenburg, Sweden
990A competing risk analysis of survival after radical cystectomy for bladder cancer patients: The impact of age at the time of surgery
By: Moschini M. 1 , Martini A. 1 , Zamboni S. 2 , Mattei A. 2 , Baumeister P. 2 , Dell'Oglio P. 1 , Zaffuto E. 1 , Burgio G. 1 , Shariat S.F. 3 , Salonia A. 1 , Montorsi F. 1 , Briganti A. 1 , Colombo R. 1 , Gallina A. 1
Institutes: 1IRCCS Ospedale San Raffaele; URI, Dept. of Urology, Division of Oncology, Milan, Italy, 2Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 3Medical University of Vienna, Dept. of Urology, Vienna, Austria
-
Specialty session - Live surgery - Robotic education, innovation and surgery session
Robotic education, innovation and surgery session Specialty session - Live surgery
Robotic education, innovation and surgery session
Specialty session - Live surgery
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
-
Aims and objectives of this session During the session robot surgical procedures will be performed and broadcasted. The audience can interact with the surgeons performing a robot assisted partial nephrectomy and robot assisted radical prostatectomy with extended lymph node dissection. Aim of the session is to show and teach surgical options and interact with the surgeons.
-
-
Poster Session 80 - Advancing the outcome of advanced and metastatic bladder cancer
Advancing the outcome of advanced and metastatic bladder cancer Poster Session 80
Advancing the outcome of advanced and metastatic bladder cancer
Poster Session 80
-
Location:Red Area, eURO Auditorium 2
-
Chairs:
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
1114Do urologists take the better slice of cake in muscle-invasive bladder cancer (MIBC)?
By: Dosanjh A. 1 , Mintz H.P. 2 , Mytton J.L. 1 , Gallier S. 1 , James N.D. 3 , Patel P. 3
Institutes: 1University Hospitals Birmingham NHS Foundation Trust, Dept. of Health Informatics, Birmingham, United Kingdom, 2University of Warwick, Warwick Medical School, Coventry, United Kingdom, 3University of Birmingham, Institute of Cancer and Genomic Sciences, Birmingham, United Kingdom
1115Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histological subtype matter?
By: Berg S. 1 , D'Andrea D. 2 , Vetterlein M.W. 3 , Cole A.P. 1 , Fletcher S.A. 1 , Krimphove M.J. 1 , Marchese M. 1 , Lipsitz S.R. 4 , Sonpavde G. 5 , Noldus J. 6 , Shariat S.F. 2 , Kibel A.S. 1 , Trinh Q-D. 1 , Mossanen M. 1
Institutes: 1Brigham and Women's Hospital, Harvard Medical School, Division of Urologic Surgery and Center for Surgery and Public Health, Boston, United States of America, 2Medical University of Vienna, Dept. of Urology, Vienna, Austria, 3University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 4Brigham and Women's Hospital, Harvard Medical School, Division of Internal Medicine and Center for Surgery and Public Health, Boston, United States of America, 5Dana Farber Cancer Institute, Harvard Medical School, Dept. of Medical Oncology, Boston, United States of America, 6Marien Hospital Herne, Ruhr-University Bochum, Dept. of Urology and NeuroUrology, Herne, Germany
1116Combination of the indoleamine 2,3-dioxygenase 1 inhibitor (IDO1i) BMS-986205 with nivolumab (nivo): Updated safety across all tumors and efficacy in advanced bladder cancer (advBC) by patient (pt) subgroup
By: Moreno V. 1 , Luke J. 2 , Gelmon K. 3 , Joshua A.M. 4 , Varga A.I. 5 , Desai J. 6 , Markman B. 7 , Gomez-Roca C.A. 8 , De Braud F. 9 , Patel S.P. 10 , Carlino M.S. 11 , Siu L.L. 12 , Curigliano G. 13 , Liu Z. 14 , Ishii Y. 15 , Wind-Rotolo M. 15 , Basciano P. 16 , Azrilevich A. 17 , Tabernero J. 18
Institutes: 1Hospital Fundacion Jimenez Diaz, Dept. of Oncology, Madrid, Spain, 2University of Chicago Medical Center, Dept. of Hematology and Oncology, Chicago, United States of America, 3University of British Columbia, BC Cancer Agency, Dept. of Medical Oncology, Vancouver, Canada, 4St Vincent’s Hospital, Dept. of Medical Oncology, Sydney, Australia, 5Gustave Roussy Cancer Campus, Dept. of Oncology, Villejuif, France, 6Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Dept. of Medical Oncology, Melbourne, Australia, 7Monash Health and Monash University, Dept. of Oncology, Melbourne, Australia, 8Institut Universitaire du Cancer de Toulouse – Oncopole, Dept. of Oncology, Toulouse, France, 9Istituto Nazionale dei Tumori, Dept. of Medical Oncology, Milan, Italy, 10University of California San Diego Moores Cancer Center, Dept. of Medical Oncology, La Jolla, United States of America, 11Westmead and Blacktown Hospitals, Melanoma Institute Australia and The University of Sydney, Dept. of Medical Oncology, Sydney, Australia, 12Princess Margaret Cancer Centre, Dept. of Medical Oncology, Toronto, Canada, 13University of Milano, Istituto Europeo di Oncologia, IRCCS, Dept. of Medical Oncology, Milan, Italy, 14Bristol-Myers Squibb, Dept. of Statistics, Princeton, United States of America, 15Bristol-Myers Squibb, Dept. of Translational Medicine, Princeton, United States of America, 16Bristol-Myers Squibb, Dept. of Clinical Trials, Princeton, United States of America, 17Bristol-Myers Squibb, Dept. of Early Clinical Development, Princeton, United States of America, 18Vall d’Hebron University Hospital, Dept. of Medical Oncology, Barcelona, Spain
1117Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
By: Batista Da Costa J. 1 , Seiler R. 2 , Ikeda K. 1 , Zhou J. 1 , Winters B. 3 , Gibb E. 4 , Volik S. 1 , Wright J. 3 , Sommerland M. 5 , Douglas J. 5 , Collins C. 1 , Black P. 1
Institutes: 1University of British Columbia, Dept. of Urologic Sciences, Vancouver, Canada, 2University of Bern, Dept. of Urology, Bern, Switzerland, 3University of Washington School of Medicine, Dept. of Urology, Seattle, United States of America, 4GenomeDX Biosciences, Dept. of R&D, Vancouver, Canada, 5University Hospital of Southampton, Dept. of Urology, Southampton, United Kingdom
1118Meta-analysis of prospective trials for bladder preserving tri-modal therapy in patients with muscle invasive bladder cancer
By: Inamoto T. 1 , Ibuki N. 1 , Komura K. 1 , Juri H. 2 , Yamamoto K. 2 , Yamamoto K. 2 , Narumi Y. 2 , Azuma H. 1
Institutes: 1Osaka Medical College, Dept. of Urology, Takatsuki, Japan, 2Osaka Medical College, Dept. of Radiology, Takatsuki, Japan
* 1119FIERCE-21: Phase 2 study of vofatamab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUCC)
By: Necchi A. 1 , Castellano D. 2 , Mellado B. 3 , Pang S.T. 4 , Urun Y. 5 , Park S.H. 6 , Vaishampayan U. 7 , Currie G. 8 , Abella E. 8 , Pal S. 9
Institutes: 1National Institute Dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2Hospital 12 de Octubre, Dept. of Medical Oncology, Madrid, Spain, 3Hospital Clinic, Dept. of Medical Oncology, Barcelona, Spain, 4Chang Gung Memorial Hospital Linkou, Dept. of Medical Oncology, Taoyuan, Taiwan, 5Ankara University School of Medicine, Dept. of Medical Oncology, Ankara, Turkey, 6Samsung Medical Center, Division of Hematology-Oncology, Seoul , South Korea, 7Karmanos Cancer Center, Dept. of Oncology, Detroit, MI, United States of America, 8BioClin Therapeutics, Inc, San Ramon, CA, United States of America, 9City of Hope, Dept. of Medical Oncology, Los Angeles, United States of America
1120Validation of the COBRA nomogram for the prediction of cancer specific survival in patients with bladder cancer treated with radical cystectomy
By: De Nunzio C. 1 , Simone G. 2 , Tuderti G. 2 , Anceschi U. 2 , Brassetti A. 2 , Daneshmand S. 3 , Miranda G. 3 , Desai M. 3 , Gill I. 3 , Abol Enein H. 4 , Molinaro E. 2 , Nacchia A. 5 , Lombardo R. 5 , Tema G. 5 , Leonardo C. 6 , Tubaro A. 5
Institutes: 1Sant'Andrea Hospital- "Sapienza" University, Dept. of Urology, Rome, Italy, 2Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 3University of Southern California, Dept. of Urology, Los Angeles, United States of America, 4Mansoura University, Dept. of Urology, Mansoura, Egypt, 5Sant'Andrea Hospital- , Dept. of Urology, Rome, Italy, 6Umberto I- "Sapienza" University, Dept. of Urology, Rome, Italy
1121Surgical outcome of pre-operative atezolizumab before radical cystectomy for muscle-invasive urothelial carcinoma of the bladder
By: Szabados B. 1 , Duran I. 2 , Crabb S.J. 3 , Van Der Heijden M.S. 4 , Font Pous A. 5 , Gravis G. 6 , Anido Herranz U. 7 , Protheroe A. 8 , Ravaud A. 9 , Maillet D. 10 , Mendez-Vidal M.J. 11 , Suárez C. 12 , Linch M.D. 13 , Prendergast A. 1 , Mousa K. 1 , Castellano D.E. 14 , Powles T. 1 , Rodriguez-Vida A. 15
Institutes: 1Queen Mary University of London, Barts Cancer Institute, London, United Kingdom, 2Hospital Universitario Marqués de Valdecilla, Dept. of Medical Oncology, Santander, Spain, 3University of Southampton, Southampton Clinical Trials Unit, Southampton, United Kingdom, 4Netherlands Cancer Institute, Dept. of Medical Oncology, Amsterdam, The Netherlands, 5Hospital Universitari Germans Trias i Pujol (HUGTiP), Institut Català d’Oncologia, Badalona, Spain, 6Institut Paoli-Calmettes, Dept. of Medical Oncology, Marseille, France, 7Hospital Clinico Universitario, Dept. of Medical Oncology, Santiago De Compostela, Spain, 8Churchill Hospital, Dept. of Medical Oncology, Oxford, United Kingdom, 9Hôpital Saint-André, Dept. of Medical Oncology, Bordeaux, France, 10Hosp Lyon SUD, Dept. of Medical Oncology, Lyon, France, 11Reina Sofía University Hospital, Dept. of Medical Oncology, Cordoba, Spain, 12Vall d’ Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain, 13Royal Marsden Hospital, Dept. of Medical Oncology, London, United Kingdom, 14Hospital Universitario , Dept. of Medical Oncology, Madrid, Spain, 15Hospital Del Mar, Dept. of Medical Oncology, Barcelona, Spain
* 1122First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (Pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC)
By: Necchi A. 1 , Bandini M. 2 , Gallina A. 2 , Bianchi M. 2 , Raggi D. 1 , Fare' E. 1 , Messina A. 1 , Chung J. 3 , Ali S. 3 , Ross J. 3 , Anichini A. 1 , Colecchia M. 1 , Gandaglia G. 2 , Fossati N. 2 , Scuderi S. 2 , Pederzoli F. 2 , Salonia A. 2 , Colombo R. 2 , Briganti A. 2 , Montorsi F. 2
Institutes: 1Fondazione IRCCS Istituto Nazionale dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2Urological Research Institute (URI), IRCCS San Raffaele Hospital, Dept. of Urology, Milan, Italy, 3Foundation Medicine, Cambridge, United States of America
1123Antihypertensive drugs and risk of bladder cancer death in Finland
By: Santala E.E. 1 , Kotsar A. 2 , Tammela T.L.J. 1 , Murtola T. 1
Institutes: 1University of Tampere, Faculty of Medicine and Life Sciences, Tampere, Finland, 2Tartu university Hospital, Dept. of Urology, Tartu, Estonia
1124Identification of stromal macrophage infiltration predict overall survival and recurrence-free survival in patients with muscle invasive bladder cancer
By: Zhu Y. , Zhang J. , Gu C. , Zhu Y. , Ye D.
Institutes: Fudan Univerisity Shanghai Cancer Center, Dept. of Urology, Shanghai, China
-
-
Poster Session 24 - Nephron sparing surgery: What can be achieved?
Nephron sparing surgery: What can be achieved? Poster Session 24
Nephron sparing surgery: What can be achieved?
Poster Session 24
330A prospective multicenter evaluation of predictive factors for positive surgical margins after partial nephrectomy for renal cell carcinoma: The RECORD2 project
By: Mari A. 1 , Di Maida F. 1 , Schiavina R. 2 , Amparore D. 3 , Antonelli A. 4 , Barale M. 5 , Borghesi M. 2 , Bove P. 6 , Brunocilla E. 2 , Capitanio U. 7 , Da Pozzo L. 8 , Gontero P. 5 , Larcher A. 7 , Longo N. 9 , Montanari E. 10 , Porpiglia F. 3 , Serni S. 1 , Simeone C. 4 , Siracusano S. 11 , Trombetta C. 12 , Volpe A. 13 , Ficarra V. 14 , Carini M. 1 , Minervini A. 1
Institutes: 1University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 2University of Bologna, Dept. of Urology, Bologna, Italy, 3San Luigi Gonzaga Hospital, Dept. of Oncology, Division of Urology, Orbassano, Italy, 4University of Brescia, Spedali Civili Hospital, Dept. of Urology, Brescia, Italy, 5University of Studies of Torino, San Giovanni Battista Hospital, Dept. of Surgical Sciences, Turin, Italy, 6University Hospital of Tor Vergata, Dept. of Urology, Rome, Italy, 7URI-Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Dept. of Urology, Milan, Italy, 8Papa Giovanni XXIII Hospital, Dept. of Urology, Bergamo, Italy, 9University Federico II of Naples, Dept. of Urology, Naples, Italy, 10Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Policlinico, University of Milan, Dept. of Urology, Milan, Italy, 11Azienda Ospedaliera Universitaria Integrata (A.O.U.I.) of Verona, Dept. of Urology, Verona, Italy, 12University of Trieste, Dept. of Urology, Trieste, Italy, 13Maggiore della Carità Hospital, Dept. of Urology, Novara, Italy, 14University of Messina, Dept. of Human and Paediatric Pathology Gaetano Barresi, Urologic Section, Messina, Italy
331Predictors of positive surgical margins after partial nephrectomy for localized renal masses: Results of a prospective multicentre study (Surface-Intermediate-Base Project)
By: Campi R. 1 , Lane B.R. 2 , De Cobelli O. 3 , Sanguedolce F. 4 , Hatzichristodoulou G. 5 , Antonelli A. 6 , Mari A. 7 , Rodriguez-Faba O. 8 , Keeley F.X. 9 , Langenhuijsen J. 10 , Klatte T. 11 , Roscigno M. 12 , Akdogan B. 13 , Furlan M. 6 , Karakoyunlu N. 14 , Marszalek M. 15 , Capitanio U. 16 , Volpe A. 17 , Brookman-May S. 18 , Smaldone M.C. 19 , Uzzo R.G. 19 , Carini M. 20 , Kutikov A. 21 , Minervini A. 20
Institutes: 1University of Florence, Dept. of Urology, Florence, Italy, 2Spectrum Health Medical Group, Dept. of Urology, Grand Rapids, United States of America, 3 European Institute of Oncology (IEO), University of Milan, Dept. of Urology, Milan, Italy, 4Southmead Hospital, Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom, 5Technical University of Munich, University Hospital Klinikum Rechts Der Isar, Dept. of Urology, Munich, Germany, 6University of Brescia, Dept. of Urology, Brescia, Italy, 7University of Florence, Dept. of Urology, University of Florence, Careggi Hospital, Florence, Italy, Florence, Italy, 8Fundacio Puigvert, Uro-oncology Unit, Barcelona, Spain, 9Southmead Hospital, Bristol Urological Unit, Dept. of Urology, Bristol, United Kingdom, 10Radboud University Nijmegen Medical Centre, Dept. of Urology, Nijmegen, The Netherlands, 11Addenbrooke’s Hospital,, Dept. of Urology, Cambridge, United Kingdom, 12ASST Papa Giovanni XXIII, Dept. of Urology, Bergamo, Italy, 13Hacettepe University, School of Medicine, Dept. of Urology, Ankara, Turkey, 14Dışkapı Yıldırım Beyazıt Training and Research Hospital,, Dept. of Urology, Ankara, Turkey, 15Graz Medical University, Dept. of Urology, Graz, Austria, 16University Vita-Salute San Raffaele, Scientific Institute Hospital San Raffaele, Dept. of Urology, Milan, Italy, 17University of Eastern Piedmont, Maggiore della Carità Hospital, Dept. of Urology, Novara, Italy, 18Ludwig-Maximilians University (LMU) Munich, Dept. of Urology, Munich, Germany, 19Fox Chase Cancer Center, Dept. of Urologic Oncology, Philadelphia, United States of America, 20University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 21Fox Chase Cancer Center, Division of Urologic Oncology, Philadelphia, United States of America
332Negative impact of positive margins in partial nephrectomy in stage 1 renal cell carcinoma: A multicenter analysis
By: Bradshaw A. 1 , Eldefrawy A. 1 , Uzzo R. 2 , Capitanio U. 3 , Patil D. 4 , Joshi S. 2 , Larcher A. 3 , Ryan S. 1 , Meagher M. 1 , Cotta B. 1 , Wan F. 1 , Montorsi F. 3 , Master V. 4 , Derweesh I. 1
Institutes: 1UC San Diego Health, Dept. of Urology, San Diego, United States of America, 2Fox Chase Cancer Center, Dept. of Urology, Philadelphia, United States of America, 3Ospadele San Raffaele, Dept. of Urology, Milan, Italy, 4Emory University, Dept. of Urology, Atlanta, United States of America
333Recurrence after nehron-sparing therapy in Sweden, a register based data study
By: Ljungberg B. 1 , Pernilla S. 2 , Magnus F. 3 , Benny H. 4 , Peter E. 5
Institutes: 1Umeå University, Surgical and perioperative sciences, Umeå, Sweden, 2Örebro University Hospital, Dept. of Urology, Örebro, Sweden, 3Sahlgrenska University Hospital, Dept of Urology, Gothenburg, Sweden, 4Uppsala University Hospital, Dept. of Urology, Uppsala, Sweden, 5Malmö University Hospital, Dept. of Urology, Malmö, Sweden
334Assessment of clinicopathological predictors of local recurrence on tumor resection bed in patients treated with partial nephrectomy for localized renal cell carcinoma (the RECORd 1 project)
By: Mari A. 1 , Tellini R. 1 , Amparore D. 2 , Antonelli A. 3 , Bianchi G. 4 , Fiori C. 5 , Furlan M. 6 , Longo N. 7 , Mirone V. 7 , Morgia G. 8 , Novara G. 9 , Porpiglia F. 10 , Schiavina R. 11 , Di Maida F. 1 , Campi R. 1 , Presutti M. 1 , Simeone C. 6 , Terrone C. 12 , Carini M. 1 , Minervini A. 1
Institutes: 1University of Florence, Dept. of Urology, University of Florence, Careggi Hospital, Florence, Italy, Florence, Italy, 2Università di Torino, Divisione di Urologia, Ospedale San Luigi Gonzaga, Orbassano, Torino, Orbassano, Turin, Italy, 3Azienda AO Spedali Civili di Brescia, Unità Operativa di Urologia, Brescia, Italy, 4Università di Modena, Clinica Urologica, Policlinico di Modena, Modena, Italy, 5Università di Torino, Ospedale San Luigi Gonzaga, Orbassano, Torino, Orbassano, Turin, Italy, 6Azienda AO Spedali Civili di Brescia, Unità Operativa di Urologia Dipartimento di NefroUrologia, Brescia, Italy, 7Università di Napoli, Policlinico Federico II, Naples, Italy, 8University of Catania, Dept. of Urology, Catania, Italy, 9Università di Padova, Clinica Urologica, Orbassano, Turin, Italy, 10Università di Torino, Ospedale San Luigi Gonzaga, Orbassano, Torino, Orbassano, Torino, Italy, 11Università di Bologna, Dipartimento di Urologia, Bologna, Italy, 12Azienda Ospedaliera Maggiore della Carità, Dipartimento di Urologia, Novara, Italy
335Patterns and predictors of late recurrence (beyond 5 years) after partial nephrectomy for renal cell carcinoma
By: Abu-Ghanem Y. , Dotan Z. , Kaver I. , Zilberman D.E. , Ramon J.
Institutes: Tel Hashomer, Dept. of Urology, Ramat Gan, Israel
336A novel trifecta to simplify the assessment of perioperative outcomes after robot assisted partial nephrectomy for cT1 renal masses: Results of a multicenter series
By: Anceschi U. 1 , Bertolo R. 2 , Brassetti A. 1 , Tuderti G. 1 , Guaglianone S. 1 , Garisto J. 3 , Kaouk J. 2 , Mottrie A. 4 , Dell'oglio P. 4 , Veccia A. 5 , Antonelli A. 5 , Capitanio U. 6 , Montorsi F. 6 , Larcher A. 6 , Minervini A. 7 , Porpiglia F. 8 , Aron M. 9 , Ithaar D. 10 , Autorino R. 11 , Swavely N. 11 , Eun D. 12 , Ferriero M. 1 , Gallucci M. 1
Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2Cleveland Clinic, Dept. of Urology, Cleveland, United States of America, 3Cleveland Clinic, Dept. of Urology, Rome, Italy, 4OLV Aalst, Dept. of Urology, Aalst, France, 5University of Brescia, Dept. of Urology, Brescia, Italy, 6San Raffaele, Dept. of Urology, Rome, Italy, 7University of Florence, Dept. of Urology, Florence, Italy, 8San Luigi Orbassano, Dept. of Urology, Orbassano, Italy, 9University of Southern California, Dept. of Urology, Los Angeles, United States of America, 10UCSD, Dept. of Urology, San Diego, United States of America, 11VCU, Dept. of Urology, Richmond, United States of America, 12Temple University, Dept. of Urology, Philadelphia, United States of America
337A preoperative nomogram to predict major complications after robot assisted partial nephrectomy
By: Khene Z-E. 1 , Peyronnet B. 1 , Bernhard J. 2 , Kocher N. 3 , Vaessen C. 4 , Doumerc N. 5 , Pradere B. 6 , Seisen T. 4 , Beauval J. 5 , Verhoest G. 1 , Roumiguié M. 5 , De La Taille A. 7 , Bruyere F. 6 , Roupret M. 4 , Méjean A. 8 , Mathieu R. 1 , Shariat S. 9 , Raman J. 3 , Bensalah K. 1
Institutes: 1University of Rennes, Dept. of Urology, Rennes, France, 2University of Bordeaux, Dept. of Urology, Bordeaux, France, 3Penn State Health Milton S. Hershey Medical Center, Dept. of Urology, Hershey, United States of America, 4La Pitie Salpétrière Hospital, Dept. of Urology, Paris, France, 5University of Toulouse, Dept. of Urology, Toulouse, France, 6University of Tours, Dept. of Urology, Tours, France, 7Mondor Hospital, Dept. of Urology, Créteil, France, 8University of Paris Descartes, Dept. of Urology, Paris, France, 9Medical University Vienna, Dept. of Urology, Vienna, Austria
338Propensity score matched comparison of minimally invasive partial and radical nephrectomy for clinical T2a renal mass: Analysis of the robotic surgery for large renal mass (ROSULA) group
By: Bradshaw A. 1 , Autorino R. 2 , Simone G. 3 , Zang C. 4 , Bertolo R. 5 , Uzzo R. 6 , Capitanio U. 7 , Porter J. 8 , Minervini A. 9 , Eun D. 10 , Lau C. 11 , Rha K. 12 , Mottrie A. 13 , Schips L. 14 , Challacombe B. 15 , Larcher A. 7 , Gallucci M. 3 , Sundaram C. 16 , Mir C. 17 , Porpiglia F. 18 , Kaouk J. 5 , Aron M. 19 , Derweesh I. 1 , ROSULA Group Collaborators
Institutes: 1UC San Diego Health, Dept. of Urology, La Jolla, United States of America, 2VCU Health, Dept. of Urology, Richmond, United States of America, 3IFO Rome, Dept. of Urology, Rome, Italy, 4Changhai Hospital, Dept. of Urology, Shanghai, China, 5Cleveland Clinic, Dept. of Urology, Cleveland, United States of America, 6Fox Chase Cancer Center, Dept. of Urology, Philadelphia, United States of America, 7Vita-Salute San Raffaele University, Dept. of Urology, Milan, Italy, 8Swedish Urology Group, Dept. of Urology, Seattle, United States of America, 9University of Florence, Dept. of Urology, Florence, Italy, 10Temple University, Dept. of Urology, Philadelphia, United States of America, 11City of Hope, Dept. of Urology, Los Angeles, United States of America, 12Yonsei University, Dept. of Urology, Seoul, South Korea, 13OLV, ORSI, Aalst, Belgium, 14University of Chieti-Pescara, Dept. of Urology, Chieti and Pescara, Italy, 15Guy's Hospital, Dept. of Urology, London, United Kingdom, 16Indiana University, Dept. of Urology, Indianapolis, United States of America, 17IVO, Dept. of Urology, Valencia, Spain, 18San Luigi Turin, Dept. of Urology, Turin, Italy, 19University of Southern California, Dept. of Urology, Los Angeles, United States of America
339Clinicopathologic factors that influence the occurrence of symptomatic pseudoaneurysm after partial nephrectomy and the influence of selective arterial embolization on postoperative renal function
By: Lee C.H. 1 , Seo W.I. 1 , Ku J.Y. 2 , Chung J.I. 1 , Park Y.J. 3 , Ha H.K. 2 , Choi S.H. 4
Institutes: 1Inje University Busan Paik Hospital, Dept. of Urology, Busan, South Korea, 2Pusan National University Hospital, Dept. of Urology, Busan, South Korea, 3Pusan National University Hospital, Dept. of Internal Medicine, Busan, South Korea, 4Kyungpook National University Hospital, Dept. of Urology, Daegu, South Korea
340Clinical and surgical predictors of medical and surgical postoperative complications in patients with limited life expectancy treated with partial nephrectomy for renal tumors: Insight from the RECORD2 project
By: Mari A. 1 , Tellini R. 1 , Gontero P. 2 , Amparore D. 3 , Antonelli A. 4 , Barale M. 5 , Bertini R. 6 , Bove P. 7 , Brunocilla E. 8 , Capitanio U. 6 , Da Pozzo L. 9 , Mirone V. 10 , Montanari E. 11 , Pisano F. 12 , Porpiglia F. 13 , Schiavina R. 8 , Serni S. 14 , Simeone C. 4 , Trombetta C. 15 , Volpe A. 16 , Artibani W. 17 , Ficarra V. 18 , Carini M. 1 , Minervini A. 1
Institutes: 1University of Florence, Dept. of Urology, University of Florence, Careggi Hospital, Florence, Italy, Florence, Italy, 2University of Studies of Torino, Divisionpof Urology, Dept. of Surgical Sciences, San Giovanni Battista Hospital, Turin, Italy, 3San Luigi Gonzaga Hospital, Division of Urology, Dept. of Oncology, San Luigi Gonzaga Hospital, School of Medicine, Orbassano, Turin, Italy, 4University of Brescia, Dept. of Urology, Spedali Civili Hospital, Brescia, Italy, 5University of Turin, Division of Urology, Dept. of Surgical Sciences, San Giovanni Battista Hospital, Turin, Italy, 6Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Unit of Urology, Division of Experimental Oncology, URI-Urological Research Institute, Milan, Italy, 7University Hospital of Tor Vergata, Dept. of Urology, Rome, Italy, 8University of Bologna, Dept. of Urology, Bologna, Italy, 9Papa Giovanni XXIII Hospital, Dept. of Urology, Bergamo, Italy, 10University Federico II of Naples, Dept. of Urology, Naples, Italy, 11University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Dept. of Urology, Milan, Italy, 12San Giovanni Battista Hospital, University of Studies of Torino, Division of Urology, Dept. f Surgical Sciences, Turin, Italy, 13San Luigi Gonzaga Hospital, School of Medicine, Division of Urology, Dept. of Oncology, Orbassano, Turin, Italy, 14University of Florence, Dept. of Urology, Unit of urological minimally invasive robotic surgery and renal transplantation, Careggi Hospital, Florence, Italy, 15University of Trieste, Dept. of Urology, Trieste, Italy, 16Maggiore della Carità Hospital, Dept. of Urology, Novara, Italy, 17Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Dept. of Urology, Verona, Italy, 18University of Messina, Dept. of Human and Paediatric Pathology; Gaetano Barresi, Urologic Section, Messina, Italy
341Retrospective comparative study between robot-assisted partial nephrectomy and open partial nephrectomy for the treatment of highly complex renal tumors with RENAL nephrometry score ≥8
By: Kim J.J. , Lee D.H. , Hong S.K. , Byun S-S.
Institutes: Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea
342Perioperative complications after partial nephrectomy for complex (PADUA score ≥ 10) renal tumors: A prospective multicenter observational study (the RECORD2 Project)
By: Mari A. 1 , Tellini R. 1 , Campi R. 1 , Amparore D. 2 , Antonelli A. 3 , Barale M. 4 , Bove P. 5 , Brunocilla E. 6 , Capitanio U. 7 , Da Pozzo L. 8 , Gontero P. 9 , Mirone V. 10 , Montanari E. 11 , Montorsi F. 12 , Porpiglia F. 2 , Schiavina R. 6 , Serni S. 1 , Simeone C. 3 , Trombetta C. 13 , Volpe A. 14 , Artibani W. 15 , Ficarra V. 16 , Carini M. 1 , Minervini A. 1
Institutes: 1University of Florence, Careggi Hospital, Dept. of Urology, Florence, Italy, 2San Luigi Gonzaga Hospital, School of Medicine, Division of Urology, Dept. of Oncology, Orbassano, Italy, 3Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 4San Giovanni Battista Hospital, University of Studies of Torino, Division of Urology, Dept. of Oncology, Turin, Italy, 5University Hospital of Tor Vergata, Dept. of Urology, Rome, Italy, 6University of Bologna, Dept. of Urology, Bologna , Italy, 7Vita- Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Division of Urology, Dept. of Oncology, Milan, Italy, 8Papa Giovanni XXIII Hospital, Dept. of Urology, Bergamo, Italy, 9San Giovanni Battista Hospital, University of Studies of Torino, Division Division of Urology, Dept. of Oncology, Turin, Italy, 10University Federico II of Naples, Dept. of Urology, Naples, Italy, 11Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Policlinico, University of Milan, Dept. of Urology, Milan, Italy, 12Vita- Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Unit of Urology, Division of Experimental Oncology, Milan, Italy, 13University of Trieste, Dept. of Urology, Trieste, Italy, 14Maggiore della Carità Hospital, Dept. of Urology, Novara, Italy, 15Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Dept. of Urology, Verona, Italy, 16University of Messina, Dept. of Urology, Messina, Italy
343Perioperative morbidity of open, laparoscopic and robotic partial nephrectomy: A prospective multicenter observational study (RECORD 2)
By: Bravi C.A. 1 , Larcher A. 1 , Capitanio U. 1 , Montorsi F. 1 , Antonelli A. 2 , Barale M. 3 , Bertini R. 1 , Bove P. 4 , Brunocilla E. 5 , Da Pozzo L. 6 , Di Maida F. 7 , Gontero P. 3 , Li Marzi V. 8 , Longo N. 9 , Montanari E. 10 , Porpiglia F. 11 , Schiavina R. 12 , Simeone C. 2 , Siracusano S. 13 , Volpe A. 14 , Ficarra V. 15 , Carini M. 11 , Mari A. 11 , Minervini A. 11
Institutes: 1Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Unit of Urology, Division of Experimental Oncology, Milan, Italy, 2Spedali Civili Hospital, University of Brescia, Dept. of Urology, Brescia, Italy, 3Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Division of Urology, Turin, Italy, 4University Hospital of Tor Vergata, Dept. of Urology, Rome, Italy, 5University of Bologna, Dept. of Urology; Department of Experimental, Diagnostic, and Specialty Medicine, Bologna, Italy, 6Papa Giovanni XXIII Hospital, Dept. of Urology, Bergamo, Italy, 7University of Florence, Careggi Hospital, Dept. of Urology, Unit of oncologic minimally-Invasive Urology and Andrology, Florence, Italy, 8University of Florence, Careggi Hospital, Dept. of Urology, Unit of urological minimally invasive robotic surgery and renal transplantation, Florence, Italy, 9University Federico II of Naples, Dept. of Urology, Naples, Italy, 10Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Policlinico, University of Milan, Dept. of Urology, Milan, Italy, 11San Luigi Gonzaga Hospital, School of Medicine, Orbassano, Division of Urology, Dept. of Oncology, Turin, Italy, 12University of Bologna, Dept. of Urology; Dept. of Experimental, Diagnostic, and Specialty Medicine, Bologna, Italy, 13Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Dept. of Urology, Verona, Italy, 14Maggiore della Carità Hospital, Dept. of Urology, Novara, Italy, 15Gaetano Barresi, University of Messina, Dept. of Human and Paediatric Pathology, Urologic Section, Messina, Italy
344Head to head impact of MIC vs a novel TRIFECTA score on oncologic and functional outcomes after robotic assisted partial nephrectomy: Results of a multicentric series
By: Anceschi U. 1 , Bertolo R. 2 , Brassetti A. 1 , Tuderti G. 1 , Capitanio U. 3 , Nandanan N. 4 , Ferriero M.C. 1 , Larcher A. 5 , Veccia A. 6 , Guaglianone S. 1 , Garisto J. 2 , Mottrie A. 7 , Antonelli A. 6 , Minervini A. 8 , Dell'Oglio P. 7 , Amparore D. 9 , Mari A. 10 , Derweesh I. 11 , Porpiglia F. 9 , Montorsi F. 5 , Koauk J. 2 , Autorino R. 4 , Gallucci M. 1 , Simone G. 1
Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2Cleveland Clinic, Dept. of Urology, Cleveland, United States of America, 3San Raffaele , Dept. of Urology, Milan, Italy, 4VCU, Dept. of Urology, Virginia, United States of America, 5San Raffaele, Dept. of Urology, Milan, Italy, 6University of Brescia, Dept. of Urology, Brescia, Italy, 7OLV Aalst, Dept. of Urology, Aalst, Belgium, 8University of Florence, Dept. of Urology, Florence, Italy, 9San Luigi Orbassano, Dept. of Urology, Orbassano, Italy, 10University of florence, Dept. of Urology, Florence, Italy, 11UCSD Health System La Jolla, Dept. of Urology, San Diego, United States of America
-
-
Green Area, Room 1
-
Urology beyond Europe - Joint Session of the European Association of Urology (EAU) and the World Chinese Urologists
Joint Session of the European Association of Urology (EAU) and the World Chinese Urologists Urology beyond Europe
Joint Session of the European Association of Urology (EAU) and the World Chinese Urologists
Urology beyond Europe
The need for patient engagement in urological cancer care To be confirmed
Laparoscopy/Robotic surgery Functional urology Urolithiasis What’s new in the Urolithiasis EAU Guidelines? To be confirmed
-
Meeting of the EAU Section of Female and Functional Urology (ESFFU) - Innovative surgical procedures in functional urology
Innovative surgical procedures in functional urology Meeting of the EAU Section of Female and Functional Urology (ESFFU)
Innovative surgical procedures in functional urology
Meeting of the EAU Section of Female and Functional Urology (ESFFU)
-
Location:Green Area, Room 1
-
Chair:
-
Aims and objectives of this session Functional urology requires expertise in a large number of complex surgeries on the lower urinary tract. Along the years, many of these surgeries incorporated numerous technical advances initially applied in other fields of urology or the result of the search for minimally-invasive procedures. The main objective of this session is to review some of the surgical innovations introduced in functional urology and discuss some of the present controversies related to the minimally-invasive treatment of female stress urinary incontinence.
-
-